Holen Sie sich die Stockscreener-App
3.18
0.32%
0.01
Handel nachbörslich:
3.25
0.07
+2.20%
Vivos Therapeutics Inc Aktie (VVOS) Neueste Nachrichten
Vivos Therapeutics Inc. stock chart pattern explainedJuly 2025 Decliners & Reliable Momentum Entry Alerts - newser.com
Historical volatility pattern of Vivos Therapeutics Inc. visualizedWeekly Investment Report & Weekly Hot Stock Watchlists - newser.com
Can Vivos Therapeutics Inc. rally from current levelsJuly 2025 Patterns & Stock Portfolio Risk Management - newser.com
How supply chain issues affect Vivos Therapeutics Inc. stock2025 Market Outlook & Smart Swing Trading Alerts - newser.com
What institutional flow reveals about Vivos Therapeutics Inc.Weekly Stock Recap & Expert Verified Stock Movement Alerts - newser.com
Is Vivos Therapeutics Inc. stock dividend yield sustainableQuarterly Profit Report & Technical Entry and Exit Tips - newser.com
Will a bounce in Vivos Therapeutics Inc. offer an exit2025 Support & Resistance & Weekly Momentum Stock Picks - newser.com
How to integrate Vivos Therapeutics Inc. into portfolio analysis toolsMarket Activity Summary & Daily Momentum Trading Reports - newser.com
Signal strength of Vivos Therapeutics Inc. stock in tech scanners2025 Bull vs Bear & Safe Capital Growth Tips - newser.com
Price momentum metrics for Vivos Therapeutics Inc. explainedProduct Launch & Low Risk Investment Opportunities - newser.com
Predicting Vivos Therapeutics Inc. trend using moving averages2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
Has Vivos Therapeutics Inc. found a price floorEntry Point & Expert Curated Trade Setup Alerts - newser.com
How moving averages guide Vivos Therapeutics Inc. tradingEarnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
Vivos Therapeutics announces sale of up to 854,332 shares by selling stockholders - MSN
Is Vivos Therapeutics Inc. forming a reversal pattern2025 Growth vs Value & Weekly Watchlist for Hot Stocks - newser.com
Vivos Therapeutics (NASDAQ:VVOS) Shares Down 1% – Time to Sell? - Defense World
What drives Vivos Therapeutics Inc stock priceGap Fill Strategies & Low Entry Investment Plans - earlytimes.in
Vivos Therapeutics Reports Clinical Data Showing Significant Improvement in ADHD and OSA Symptoms in Children Using FDA-Cleared DNA Appliance - Quiver Quantitative
58% Drop in ADHD Symptoms: Vivos' FDA-Cleared Sleep Device Shows Breakthrough in Children's Treatment - Stock Titan
What analysts say about Vivos Therapeutics Inc stockTrendline Breakouts & High Yield Investment Tips - earlytimes.in
Vivos Therapeutics Inc Stock Analysis and ForecastMarket Insider Reports & Affordable Capital Growth - earlytimes.in
The Future of Sleep Apnea Treatment: Vivos’ Oral Appliance Technology Offers an Alternative to CPAP - MarketScale
Will Vivos Therapeutics Inc. rebound enough to break even2025 EndofYear Setup & Safe Capital Investment Plans - newser.com
Using economic indicators to assess Vivos Therapeutics Inc. potentialRate Hike & Safe Swing Trade Setups - newser.com
Comparing Vivos Therapeutics Inc. in custom built stock radarsMarket Movement Recap & Community Supported Trade Ideas - newser.com
Market Catalysts: What are Vivos Therapeutics Incs earnings expectationsEarnings Risk Report & Consistent Income Trade Ideas - خودرو بانک
Quarterly Recap: Is Vivos Therapeutics Inc. part of any ETFIndex Update & Risk Controlled Swing Alerts - khodrobank.com
Growth Value: What’s the outlook for NNBR’s sectorJuly 2025 EndofMonth & Momentum Based Trading Ideas - khodrobank.com
1.19%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):